PGAM
FBRX icon

Princeton Global Asset Management’s Forte Biosciences FBRX Stock Holding History

Princeton Global Asset Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1
Closed -$1K – 502
2020
Q4 		$1K Hold
1
– – ﹤0.01% 460
2020
Q3 		$2K Buy
+1
New +$663 ﹤0.01% 416
2020
Q2 		– Sell
-1
Closed -$1K – 526
2020
Q1 		$1K Hold
1
– – ﹤0.01% 467
2019
Q4 		$1 Hold
1
– – ﹤0.01% 488
2019
Q3 		$1K Buy
+1
New +$1.52K ﹤0.01% 341
2019
Q2 		– Sell
-1
Closed -$5K – 390
2019
Q1 		$5K Buy
+1
New +$3.86K ﹤0.01% 311

Other funds holding FBRX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Princeton Global Asset Management's FBRX Position: Q1 2021 in Review

Princeton Global Asset Management sold out of Forte Biosciences (FBRX) in Q1 2021, closing a stake of 1 share — an estimated $1K sold.

Princeton Global Asset Management first reported a position in FBRX in Q1 2019 and held it in 6 quarters. The position peaked at $5K in Q1 2019. 62 funds tracked by Wall St. Rank hold FBRX as of Q1 2021.

  • Princeton Global Asset Management reported no remaining Forte Biosciences position as of Q1 2021 after selling out during the quarter.
  • Princeton Global Asset Management sold 1 Forte Biosciences share in Q1 2021, an estimated $1K.
  • Princeton Global Asset Management first reported a position in Forte Biosciences in Q1 2019 and held it in 6 quarters.
  • Princeton Global Asset Management's Forte Biosciences position peaked at $5K in Q1 2019.
  • 62 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2021.

Based on Princeton Global Asset Management's 13F filing for Q1 2021, filed 11 May 2021.